Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma
出版年份 2021 全文链接
标题
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma
作者
关键词
-
出版物
GUT
Volume -, Issue -, Pages gutjnl-2020-321175
出版商
BMJ
发表日期
2021-01-25
DOI
10.1136/gutjnl-2020-321175
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer
- (2020) Arianna Fumagalli et al. Cell Stem Cell
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts
- (2019) Maartje van der Heijden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation
- (2019) Kazuto Harada et al. ANNALS OF SURGERY
- Lineage tracing and targeting of IL17RB+tuft cell-like human colorectal cancer stem cells
- (2019) Norihiro Goto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
- (2018) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer
- (2018) Kristiaan J. Lenos et al. NATURE CELL BIOLOGY
- YAP1-mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the combination of YAP1 and CDK4/6 inhibitors in Esophageal Cancer
- (2018) Fan Li et al. CLINICAL CANCER RESEARCH
- Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set
- (2018) N. del-Toro et al. Nature Communications
- Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy
- (2017) Ishna N. Mistry et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Intra-tumor heterogeneity from a cancer stem cell perspective
- (2017) Pramudita R. Prasetyanti et al. Molecular Cancer
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Targeting the Colorectal Cancer Stem Cell
- (2017) Jan Paul Medema NEW ENGLAND JOURNAL OF MEDICINE
- Gastric adenocarcinoma
- (2017) Jaffer A. Ajani et al. Nature Reviews Disease Primers
- Post-Chemoradiation Surgical Pathology Stage Can Customize the Surveillance Strategy in Patients With Esophageal Adenocarcinoma
- (2017) Takashi Taketa et al. Journal of the National Comprehensive Cancer Network
- Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
- (2016) K.-W. Lee et al. CLINICAL CANCER RESEARCH
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
- (2015) V. Adorno-Cruz et al. CANCER RESEARCH
- The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer
- (2015) S. Song et al. CLINICAL CANCER RESEARCH
- Esophageal and Esophagogastric Junction Cancers, Version 1.2015
- (2015) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- YAP and the drug resistance highway
- (2015) Alona Keren-Paz et al. NATURE GENETICS
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- Cancer Stem Cells: The Promise and the Potential
- (2015) Jaffer A. Ajani et al. SEMINARS IN ONCOLOGY
- Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties
- (2014) S. Song et al. CANCER RESEARCH
- Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer
- (2014) Kazuki Sudo et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Loss of TGF- Adaptor 2SP Activates Notch Signaling and SOX9 Expression in Esophageal Adenocarcinoma
- (2013) S. Song et al. CANCER RESEARCH
- Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy
- (2013) Anthony Linton et al. Clinical Genitourinary Cancer
- The Stress Protein BAG3 Stabilizes Mcl-1 Protein and Promotes Survival of Cancer Cells and Resistance to Antagonist ABT-737
- (2013) Mariana Boiani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients
- (2013) J.A. Ajani et al. Molecular Oncology
- Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort
- (2012) N. K. S. Cheedella et al. ANNALS OF ONCOLOGY
- Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma
- (2012) W. W. Lockwood et al. CLINICAL CANCER RESEARCH
- Metronomic Dosing of BH3 Mimetic Small Molecule Yields Robust Antiangiogenic and Antitumor Effects
- (2011) A. Imai et al. CANCER RESEARCH
- Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
- (2011) W. Kang et al. CLINICAL CANCER RESEARCH
- Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer
- (2011) Neal Ready et al. Journal of Thoracic Oncology
- Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma
- (2008) L. Paoluzzi et al. BLOOD
- AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
- (2008) K. Balakrishnan et al. BLOOD
- ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
- (2008) Julie Douville et al. STEM CELLS AND DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started